Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 95
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Int J Urol ; 30(12): 1155-1163, 2023 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-37665144

RESUMEN

OBJECTIVES: Clinical guidelines recommend that patients with non-muscle-invasive bladder cancer (NMIBC) should be treated with appropriate adjuvant therapy. However, compliance with guideline recommendations is insufficient, and this may lead to unfavorable outcomes. We aimed to investigate the level of adherence to guideline recommendations in patients with NMIBC and evaluate the outcomes of those who did and did not receive guideline-recommended therapies. METHODS: We performed a retrospective analysis of patients with histologically diagnosed NMIBC. The percentage of patients with intermediate- and high-risk tumors who received adjuvant intravesical therapy or second transurethral resection (TUR) was calculated. Recurrence-free survival was assessed in patients who did and did not receive the therapies. We conducted a propensity score-matched analysis to compare outcomes between patients with intermediate-risk and T1 NMIBC who did and did not undergo guideline-recommended therapies. RESULTS: Overall, 1204 patients from the Tohoku Urological Evidence-Based Medicine Study Group and Kyoto University Hospital were included. Of patients with intermediate- and high-risk tumors, 91.0% and 74.0% did not receive maintenance bacillus Calmette-Guérin (BCG), respectively. In both groups, significantly better recurrence-free survival was found for patients treated with maintenance BCG. Among patients with T1 NMIBC, only 16.7% underwent guideline-recommended therapies, that is, a second TUR and maintenance BCG. Significantly greater recurrence-free survival was observed in patients who received guideline-recommended therapies compared with propensity-matched patients who did not. CONCLUSIONS: Guideline-recommended therapies may contribute to improvements in outcomes for patients with NMIBC, suggesting that improvements in adherence to clinical guidelines may lead to favorable outcomes.


Asunto(s)
Neoplasias Vesicales sin Invasión Muscular , Neoplasias de la Vejiga Urinaria , Humanos , Estudios Retrospectivos , Vacuna BCG/uso terapéutico , Adyuvantes Inmunológicos/uso terapéutico , Administración Intravesical , Neoplasias de la Vejiga Urinaria/patología , Invasividad Neoplásica , Recurrencia Local de Neoplasia/epidemiología , Recurrencia Local de Neoplasia/prevención & control , Recurrencia Local de Neoplasia/tratamiento farmacológico
2.
Int J Urol ; 29(12): 1517-1523, 2022 12.
Artículo en Inglés | MEDLINE | ID: mdl-36094740

RESUMEN

OBJECTIVES: To investigate how much minimal residual membranous urethral length (mRUL) and maximal urethral length (MUL) measured on MRI preoperatively affect postoperative urinary incontinence (PUI) and recovery in robot-assisted radical prostatectomy (RARP) and open radical prostatectomy (ORP). METHODS: The subjects were 190 and 110 patients undergoing RARP and ORP, respectively, in our institution. Patients underwent preoperative MRI for prostate cancer evaluation and completed the quality of life questionnaire of the Expanded Prostate Cancer Index Composite instrument before and 1, 3, 6, and 12 months after surgery. The parameters of mRUL and MUL were measured on MRI and analyzed along with other parameters including age, body mass index, and nerve sparing. RESULTS: The median mRUL and MUL were 7.81 and 14.27 mm in the RARP group and 7.15 and 13.57 mm in the ORP group, respectively. Recovery rates from PUI were similar in the two groups. Multivariate analyses showed that mRUL was a predictor of baseline continence, whereas shorter MUL was a predictor of poor recovery from PUI. Patients with both shorter mRUL and MUL had significantly worse recoveries from PUI after RARP and ORP than patients with longer mRUL and MUL. CONCLUSIONS: Minimal residual membranous urethral length contributes to urethral function as basal urinary continence, whereas MUL represents the potential of recovery from PUI in RARP and ORP. The MUL measured by preoperative MRI can predict poor recovery from PUI after radical prostatectomy and combined evaluation of MUL and mRUL support to anticipate poor recovery of PUI.


Asunto(s)
Neoplasias de la Próstata , Procedimientos Quirúrgicos Robotizados , Robótica , Incontinencia Urinaria , Masculino , Humanos , Calidad de Vida , Complicaciones Posoperatorias/epidemiología , Complicaciones Posoperatorias/etiología , Prostatectomía/efectos adversos , Incontinencia Urinaria/etiología , Procedimientos Quirúrgicos Robotizados/efectos adversos , Neoplasias de la Próstata/diagnóstico por imagen , Neoplasias de la Próstata/cirugía , Recuperación de la Función
3.
Sensors (Basel) ; 22(24)2022 Dec 08.
Artículo en Inglés | MEDLINE | ID: mdl-36559978

RESUMEN

This paper presents a method for estimating the six Degrees of Freedom (6DoF) pose of texture-less objects from a monocular image by using edge information. The deep learning-based pose estimation method needs a large dataset containing pairs of an image and ground truth pose of objects. To alleviate the cost of collecting a dataset, we focus on the method using a dataset made by computer graphics (CG). This simulation-based method prepares a thousand images by rendering the computer-aided design (CAD) data of the object and trains a deep-learning model. As an inference stage, a monocular RGB image is entered into the model, and the object's pose is estimated. The representative simulation-based method, Pose Interpreter Networks, uses silhouette images as the input, thereby enabling common feature (contour) extraction from RGB and CG images. However, estimating rotation parameters is less accurate. To overcome this problem, we propose a method to use edge information extracted from the object's ridgelines for training the deep learning model. Since edge distribution changes largely according to the pose, the estimation of rotation parameters becomes more robust. Through an experiment with simulation data, we quantitatively proved the accuracy improvement compared to the previous method (error rate decreases at a certain condition are translation 22.9% and rotation: 43.4%). Moreover, through an experiment with physical data, we clarified the issues of this method and proposed an effective solution by fine-tuning (error rate decrease at a certain condition are translation 20.1% and rotation 57.7%).


Asunto(s)
Simulación por Computador
4.
Sensors (Basel) ; 22(3)2022 Jan 20.
Artículo en Inglés | MEDLINE | ID: mdl-35161519

RESUMEN

Event cameras are bio-inspired sensors that have a high dynamic range and temporal resolution. This property enables motion estimation from textures with repeating patterns, which is difficult to achieve with RGB cameras. Therefore, motion estimation of an event camera is expected to be applied to vehicle position estimation. An existing method, called contrast maximization, is one of the methods that can be used for event camera motion estimation by capturing road surfaces. However, contrast maximization tends to fall into a local solution when estimating three-dimensional motion, which makes correct estimation difficult. To solve this problem, we propose a method for motion estimation by optimizing contrast in the bird's-eye view space. Instead of performing three-dimensional motion estimation, we reduced the dimensionality to two-dimensional motion estimation by transforming the event data to a bird's-eye view using homography calculated from the event camera position. This transformation mitigates the problem of the loss function becoming non-convex, which occurs in conventional methods. As a quantitative experiment, we created event data by using a car simulator and evaluated our motion estimation method, showing an improvement in accuracy and speed. In addition, we conducted estimation from real event data and evaluated the results qualitatively, showing an improvement in accuracy.


Asunto(s)
Movimiento (Física) , Recolección de Datos
5.
Sensors (Basel) ; 20(19)2020 Sep 23.
Artículo en Inglés | MEDLINE | ID: mdl-32977436

RESUMEN

Human motion capture (MoCap) plays a key role in healthcare and human-robot collaboration. Some researchers have combined orientation measurements from inertial measurement units (IMUs) and positional inference from cameras to reconstruct the 3D human motion. Their works utilize multiple cameras or depth sensors to localize the human in three dimensions. Such multiple cameras are not always available in our daily life, but just a single camera attached in a smart IP devices has recently been popular. Therefore, we present a 3D pose estimation approach from IMUs and a single camera. In order to resolve the depth ambiguity of the single camera configuration and localize the global position of the subject, we present a constraint which optimizes the foot-ground contact points. The timing and 3D positions of the ground contact are calculated from the acceleration of IMUs on foot and geometric transformation of foot position detected on image, respectively. Since the results of pose estimation is greatly affected by the failure of the detection, we design the image-based constraints to handle the outliers of positional estimates. We evaluated the performance of our approach on public 3D human pose dataset. The experiments demonstrated that the proposed constraints contributed to improve the accuracy of pose estimation in single and multiple camera setting.


Asunto(s)
Aceleración , Pie , Humanos , Movimiento (Física)
6.
Hinyokika Kiyo ; 66(1): 29-32, 2020 Jan.
Artículo en Japonés | MEDLINE | ID: mdl-32028753

RESUMEN

Approximately 400 cases of penile fracture have been reported in Japan, but the sexual function before and after treatment has not been evaluated. Here, we show 2 surgical procedures dealing with penile fractureand examinethechange s in sexual functions using IIEF-5. Case1 was in a 51 year old malewho underwent emergency surgery for a penile fracture. The IIEF-5 score was 17 points before surgery and 8 points 2 months after surgery. At 5 months post-surgery, the patient complained of mild pain and penile curvature while erect, still the IIEF-5 score showed an improvement to 12 points. Case 2 was in a 60 year old male who underwent emergency surgery for penile fracture. The IIEF-5 score was 21 points before surgery and 8 points 2 months after surgery. Erection and ejaculation became possible 6 months after surgery, and the IIEF-5 score showed an improvement to 21 points. After surgery, the IIEF-5 score declined and sexual function also declined temporarily, though both gradually improved. From a sexual functioning standpoint, surgical treatment would be preferable.


Asunto(s)
Enfermedades del Pene , Humanos , Japón , Masculino , Persona de Mediana Edad , Erección Peniana , Pene
7.
Immunity ; 33(5): 817-29, 2010 Nov 24.
Artículo en Inglés | MEDLINE | ID: mdl-21093315

RESUMEN

Heparan sulfate can bind several adhesion molecules involved in lymphocyte trafficking. However, the in vivo function of endothelial heparan sulfate in lymphocyte homing and stimulation of the immune response has not been elucidated. Here, we generated mutant mice deficient in the enzyme Ext1, which is required for heparan sulfate synthesis, in a Tek-dependent and inducible manner. Chemokine presentation was diminished in the mutant mice, causing the lack of appropriate integrin-mediated adhesion, and resulted in a marked decrease in lymphocyte sticking to high endothelial venules and in recruitment of resident dendritic cells through lymphatic vessels to the lymph nodes. As a consequence, mutant mice displayed a severe impairment in lymphocyte homing and a compromised contact hypersensitivity response. By contrast, lymphocyte rolling was increased because of loss of electrostatic repulsion by heparan sulfate. These results demonstrate critical roles of endothelial heparan sulfate in immune surveillance and immune response generation.


Asunto(s)
Quimiocinas/inmunología , Células Dendríticas/inmunología , Heparitina Sulfato/inmunología , Ganglios Linfáticos/inmunología , Linfocitos/inmunología , Animales , Adhesión Celular/inmunología , Quimiocinas/metabolismo , Células Dendríticas/metabolismo , Endotelio Vascular/inmunología , Heparitina Sulfato/metabolismo , Integrinas/inmunología , Ganglios Linfáticos/metabolismo , Linfocitos/metabolismo , Ratones , Ratones Endogámicos C57BL , N-Acetilglucosaminiltransferasas/deficiencia , Vénulas/inmunología , Vénulas/metabolismo
8.
Int J Clin Oncol ; 23(5): 936-943, 2018 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-29860539

RESUMEN

BACKGROUND: The aim was to investigate the relationships between total sunitinib plasma concentrations (sunitinib plus its active metabolite; N-desethyl sunitinib) and clinical outcomes in Japanese patients with metastatic renal cell carcinoma (mRCC). METHODS: Twenty patients with mRCC were enrolled following treatment with sunitinib. To assess safety, the total sunitinib concentration range up to discontinuation of treatment and dosage reduction associated with adverse events within 6 weeks from initiating administration were analyzed. The longest administered sunitinib dosage was defined as the maintenance dose, and the relationship between total sunitinib concentration at the maintenance dosage and sunitinib efficacy was investigated. RESULTS: Total sunitinib concentration was significantly higher in patients who discontinued treatment or had dosage reduction due to adverse events within 6 weeks after initiation of sunitinib than in patients who continued treatment with the initial dosage. The time to treatment failure, progression-free survival, and overall survival were better in patients with total sunitinib concentrations < 50 ng/mL than in those with concentrations ≥ 50 ng/mL. CONCLUSIONS: The present study demonstrated that the effective range of total sunitinib concentration in Japanese patients with mRCC was lower than 50-100 ng/mL which was previously reported. These results indicate that therapeutic drug monitoring could maintain the therapeutic effect of sunitinib while minimizing adverse events by personalizing sunitinib dosages for Japanese patients with mRCC.


Asunto(s)
Antineoplásicos/sangre , Carcinoma de Células Renales/mortalidad , Indoles/sangre , Neoplasias Renales/mortalidad , Pirroles/sangre , Anciano , Antineoplásicos/administración & dosificación , Carcinoma de Células Renales/sangre , Carcinoma de Células Renales/tratamiento farmacológico , Carcinoma de Células Renales/patología , Relación Dosis-Respuesta a Droga , Femenino , Humanos , Indoles/administración & dosificación , Japón , Neoplasias Renales/sangre , Neoplasias Renales/tratamiento farmacológico , Neoplasias Renales/patología , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Pirroles/administración & dosificación , Sunitinib , Tasa de Supervivencia , Insuficiencia del Tratamiento
9.
Glycoconj J ; 34(2): 267-273, 2017 04.
Artículo en Inglés | MEDLINE | ID: mdl-28205070

RESUMEN

Disialosyl globopentaosylceramide (DSGb5) is a ganglioside originally isolated from tissue extracts of renal cell carcinoma (RCC) with metastasis. Previous in vitro experiments have suggested that DSGb5 promotes metastasis by enhancing the migration of RCC cells and downregulating NK cell cytotoxicity against RCC cells. In this study, we investigated the clinicopathological significance of DSGb5 expression in RCC and outcomes of RCC patients. A total of 156 RCC patients who underwent surgical treatments at our hospital from January 2007 through December 2012 were analyzed in this study. The expression of DSGb5 in RCC specimens was examined by immunohistochemical staining with monoclonal antibody 5F3. The immunostaining intensity of RCC tissues was assessed in comparison with that in benign renal tubules as an internal positive control. The relationship between DSGb5 expression and clinicopathological characteristics was investigated and recurrence free survival following surgery was evaluated. Microvascular invasion was observed in 68% (n = 19/28) and in 45% (n = 58/128) of the DSGb5 high expression group and low expression group, respectively (p = 0.031). Of 156 patients with a median follow up of 51 months, 18 patients (12%) developed metastasis following surgery. Patients in the DSGb5 high expression group showed significantly lower recurrence-free survival as compared with those in the DSGb5 low expression group (log-rank P = 0.047). In the present study, DSGb5 expression was associated with microvascular invasion in RCC tissues, and patients with DSGb5 high expression showed significantly lower recurrence-free survival rates. These findings suggest that DSGb5 expressed in RCC is correlated with metastasis and is a potential predictor for identifying patients who experience metastasis after surgery.


Asunto(s)
Carcinoma de Células Renales , Regulación Neoplásica de la Expresión Génica , Globósidos/biosíntesis , Neoplasias Renales , Túbulos Renales Distales , Anciano , Anticuerpos Monoclonales de Origen Murino/química , Antineoplásicos Inmunológicos/química , Carcinoma de Células Renales/metabolismo , Carcinoma de Células Renales/mortalidad , Carcinoma de Células Renales/patología , Carcinoma de Células Renales/cirugía , Supervivencia sin Enfermedad , Femenino , Humanos , Inmunohistoquímica , Neoplasias Renales/metabolismo , Neoplasias Renales/mortalidad , Neoplasias Renales/patología , Neoplasias Renales/cirugía , Túbulos Renales Distales/metabolismo , Túbulos Renales Distales/patología , Masculino , Persona de Mediana Edad , Metástasis de la Neoplasia , Tasa de Supervivencia
10.
Int J Colorectal Dis ; 32(12): 1687-1692, 2017 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-28956135

RESUMEN

PURPOSE: The procedure for prolapse and hemorrhoids (PPH) has the advantage of less postoperative pain. However, serious postoperative complications have been reported after PPH, and the postoperative recurrence rate is high in comparison with conventional Milligan-Morgan hemorrhoidectomy (MMH). The purpose of this study was to evaluate PPH with low rectal anastomosis (PPH-LA) in comparison with the original PPH and MMH. METHODS: Among a total of 1315 patients with hemorrhoids, MMH was conducted in 322, original PPH using a PPH 01 stapler (PPH01) in 63, PPH-LA using 01 (PPH-LA01) in 236, 03 (PPH-LA03) in 649, and sclerotherapy (SCL) in 45. RESULTS: Length of hospital stay and number of working days lost were significantly greater for MMH than for any form of PPH. The rate of massive postoperative bleeding was significantly lower after PPH-LA03 than after PPH01 or PPH-LA01. No serious postoperative complications occurred after any form of PPH. A significantly higher proportion of patients complained of continued prolapse after PPH01 than after MMH, PPH-LA01, or -LA03. The 5- and 16-year postoperative cumulative recurrence rates after PPH-LA03 were significantly lower than after PPH01. CONCLUSIONS: The postoperative cumulative recurrence rate after PPH-LA03 is as low as that after MMH for up to 16 years, and compared with the original PPH01, the effectiveness is higher and the postoperative cumulative recurrence rate for up to 16 years is significantly lower. We conclude that PPH-LA03 is a superior procedure for hemorrhoids, having less postoperative pain and a low rate of recurrence.


Asunto(s)
Hemorreoidectomía/instrumentación , Hemorroides/cirugía , Prolapso Rectal/cirugía , Recto/cirugía , Engrapadoras Quirúrgicas , Grapado Quirúrgico/instrumentación , Absentismo , Adulto , Anciano , Anastomosis Quirúrgica , Diseño de Equipo , Femenino , Hemorreoidectomía/efectos adversos , Hemorreoidectomía/métodos , Hemorroides/diagnóstico , Humanos , Tiempo de Internación , Masculino , Persona de Mediana Edad , Dolor Postoperatorio/etiología , Hemorragia Posoperatoria/etiología , Prolapso Rectal/diagnóstico , Recurrencia , Estudios Retrospectivos , Reinserción al Trabajo , Factores de Riesgo , Escleroterapia , Ausencia por Enfermedad , Grapado Quirúrgico/efectos adversos , Factores de Tiempo , Resultado del Tratamiento
11.
Int J Clin Oncol ; 22(1): 166-173, 2017 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-27614621

RESUMEN

OBJECTIVE: To examine the antitumor activity of zoledronic acid (ZA) combined with androgen deprivation therapy (ADT) for men with treatment-naive prostate cancer and bone metastasis. METHODS: We enrolled 227 men with treatment-naive prostate cancer and bone metastasis. Participants were randomly assigned (1:1 ratio) to receive combined androgen blockade alone (CAB group) or ZA with combined androgen blockade (CZ group). Time to treatment failure (TTTF), time to the first skeletal-related event (TTfSRE), and overall survival (OS) rates were estimated using the Kaplan-Meier method. Hazard ratios (HRs) were calculated using the Cox proportional hazards model. Median follow-up duration was 41.5 months. RESULTS: Median TTTFs were 12.4 and 9.7 months for the CZ and CAB groups, respectively (HR 0.75; 95 % CI 0.57-1.00; p = 0.051). For men with baseline prostate-specific antigen levels <200 ng/mL, median TTTFs were 23.7 and 9.8 months for the CZ and CAB groups, respectively (HR 0.58; 95 % CI 0.35-0.93; p = 0.023). Median TTfSREs were 64.7 and 45.9 months for the CZ and CAB groups, respectively (HR 0.58; 95 % CI 0.38-0.88; p = 0.009). OS was similar between the groups. CONCLUSIONS: This study failed to demonstrate that combined use of ZA and ADT significantly prolonged TTTF in men with treatment-naive prostate cancer and bone metastasis. However, it generates a new hypothesis that the combined therapy could delay the development of castration resistance in a subgroup of patients with low baseline prostate-specific antigen values <200 ng/mL. The treatment also significantly prolonged TTfSRE but did not affect OS.


Asunto(s)
Antagonistas de Andrógenos/administración & dosificación , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Neoplasias Óseas/tratamiento farmacológico , Difosfonatos/administración & dosificación , Imidazoles/administración & dosificación , Neoplasias de la Próstata/tratamiento farmacológico , Anciano , Anciano de 80 o más Años , Neoplasias Óseas/sangre , Neoplasias Óseas/secundario , Supervivencia sin Enfermedad , Estudios de Seguimiento , Humanos , Estimación de Kaplan-Meier , Masculino , Persona de Mediana Edad , Modelos de Riesgos Proporcionales , Antígeno Prostático Específico/sangre , Neoplasias de la Próstata/sangre , Neoplasias de la Próstata/patología , Tasa de Supervivencia , Factores de Tiempo , Insuficiencia del Tratamiento , Ácido Zoledrónico
12.
J Orthop Sci ; 22(2): 345-350, 2017 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-28017710

RESUMEN

BACKGROUND: Several lines of evidence indicate that the active form of vitamin D has an anabolic effect on skeletal muscle. Eldecalcitol, an analogue of the active form of vitamin D, has the potential to increase bone density and decrease fracture risk. The objective of this study was to investigate the effect of eldecalcitol in C2C12 myogenic cells. METHODS: C2C12 cells were grown to confluency and the culture medium was replaced with low-glucose DMEM containing 2% horse serum. Eldecalcitol was added at a concentration of 1, 10 or 100 nM. Gene expression profiles of vitamin D receptor (VDR), MyoD, IGF-1, neonatal myosin heavy chain (MHC), and the fast MHC subtypes Ia, IIa, IIb and IId/x were analyzed by quantitative RT-PCR. Protein expression of MHC subtypes was evaluated by western blotting and immunostaining. RESULTS: Eldecalcitol upregulated gene expression of VDR, MyoD and IGF-1. Incubation with eldecalcitol in the absence of serum followed by the addition of serum after 1 h was associated with greater increases in the expression of these genes compared with co-incubation with eldecalcitol and serum. Gene expression of MHC subtypes IIa, IIb and IId/x was significantly increased by eldecalcitol. Protein expression of fast MHC subtypes was significantly increased by eldecalcitol at 1 and 10 nM. CONCLUSION: Similar to the active form of vitamin D, eldecalcitol had an anabolic effect on fast MHC subtypes. Taking into account its pharmacokinetic profile, eldecalcitol is expected to be beneficial for the maintenance and improvement of muscle function in elderly individuals.


Asunto(s)
Mioblastos/efectos de los fármacos , Cadenas Pesadas de Miosina/efectos de los fármacos , Receptores de Calcitriol/genética , Vitamina D/análogos & derivados , Análisis de Varianza , Animales , Western Blotting , Diferenciación Celular/efectos de los fármacos , Células Cultivadas , Técnica del Anticuerpo Fluorescente , Regulación de la Expresión Génica , Ratones , Mioblastos/citología , ARN/análisis , Reacción en Cadena en Tiempo Real de la Polimerasa , Receptores de Calcitriol/efectos de los fármacos , Vitamina D/farmacología
13.
BJU Int ; 117(3): 450-5, 2016 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-25684579

RESUMEN

OBJECTIVE: To perform a longitudinal investigation of the correlation between functional recovery and sex hormone concentrations after radical prostatectomy (RP). PATIENTS AND METHODS: A total of 72 consecutive patients undergoing RP between January 2012 and June 2013 were prospectively included and serially followed after surgery for comparative analysis. Their luteinizing hormone (LH) and total testosterone (TT) concentrations were measured before surgery and 3 and 12 months after surgery. They also filled out a health-related quality of life questionnaire before and at 1, 3, 6 and 12 months after surgery. RESULTS: The mean LH concentration increased from 4.28 U/L at baseline to 5.53 U/L at 3 months and remained high at 12 months after RP (both P < 0.001). There were no significant changes in the TT concentration after RP. LH at baseline was negatively correlated with the urinary function (UF) score at 3 and 12 months after RP (P = 0.030 and 0.032, respectively). After RP, subjects with high baseline LH (n = 37) were more likely than those with low LH concentrations to report lower UF scores (P = 0.014). Multivariate analysis of variance in an interaction of time × LH concentration for UF scores indicated a significant relationship between changes in UF score and LH concentration (P = 0.004). CONCLUSIONS: Radical prostatectomy affects sex hormones by increasing LH concentrations, while TT concentrations remain stable after surgery. Baseline LH concentrations are significantly associated with the recovery of urinary outcomes after RP.


Asunto(s)
Hormona Luteinizante/metabolismo , Prostatectomía/métodos , Neoplasias de la Próstata/cirugía , Retención Urinaria/cirugía , Anciano , Humanos , Masculino , Persona de Mediana Edad , Cuidados Posoperatorios , Cuidados Preoperatorios , Estudios Prospectivos , Neoplasias de la Próstata/sangre , Neoplasias de la Próstata/fisiopatología , Calidad de Vida , Recuperación de la Función , Testosterona/metabolismo , Retención Urinaria/sangre , Retención Urinaria/fisiopatología
14.
Int J Urol ; 23(6): 478-83, 2016 06.
Artículo en Inglés | MEDLINE | ID: mdl-27021804

RESUMEN

OBJECTIVES: To verify whether abdominal pressure during urination represents an important factor in the postoperative development of inguinal hernia after radical retropubic prostatectomy. METHODS: Participants comprised 228 patients who underwent radical retropubic prostatectomy without prophylaxis for inguinal herniation between 2002 and 2007. Development of inguinal hernia was assessed from clinical records. Straining was rated on a six-point scale (straining score) according to frequency of straining using answers to question 6 of the International Prostate Symptom Score questionnaire preoperatively, and at 1, 3, 6, 12, 18, 24 and 36 months after prostatectomy. Straining scores were compared between patients with and without postoperative inguinal hernia. Multivariate analysis was carried out to identify parameters associated with inguinal hernia development after prostatectomy. Associations between inguinal hernia development and frequency of postoperative urinary straining were also estimated. RESULTS: Straining score in both groups was significantly increased at 1 month after radical retropubic prostatectomy. This increase was significantly greater in the postoperative inguinal hernia group (P < 0.05). Throughout the observation period, postoperative straining scores were higher in the group with postoperative inguinal hernia than in the group without. On multivariate analysis, postoperative urinary straining and previous hernia repair represented significant risk factors for postoperative inguinal hernia. The proportion of patients without inguinal hernia decreased significantly with increasing frequency of postoperative urinary straining. CONCLUSION: Urinary straining is associated with inguinal hernia development after radical retropubic prostatectomy.


Asunto(s)
Hernia Inguinal/etiología , Prostatectomía/efectos adversos , Neoplasias de la Próstata/cirugía , Trastornos Urinarios/complicaciones , Humanos , Incidencia , Masculino , Estudios Retrospectivos , Trastornos Urinarios/etiología
15.
Int J Urol ; 22(7): 710-2, 2015 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-25881870

RESUMEN

Treatment for ruptured renal angiomyolipoma in pregnancy requires immediate and appropriate decision-making based on the condition of the mother and fetus, and gestational age. A 37-year-old woman at 25 weeks of pregnancy presented with severe right flank pain. Computed tomography showed a ruptured right renal angiomyolipoma (8 cm in diameter). The maternal and fetal conditions were stable. Transcatheter arterial embolization was carried out electively 4 days after the rupture. Minimization of radiation exposure to the fetus was achieved by X-ray shielding for the fetus, low-dose-rate fluoroscopy, minimal angiography imaging and a color Doppler ultrasonography-guided procedure. Although threatened premature labor occurred because of post-embolization syndrome, the pregnancy was continued until cesarean section at 37 weeks of pregnancy.


Asunto(s)
Angiomiolipoma/diagnóstico , Angiomiolipoma/cirugía , Embolización Terapéutica/métodos , Neoplasias Renales/diagnóstico , Neoplasias Renales/cirugía , Adulto , Femenino , Humanos , Embarazo , Rotura Espontánea , Tomografía Computarizada por Rayos X , Ultrasonografía Doppler
16.
Hinyokika Kiyo ; 61(3): 109-14, 2015 Mar.
Artículo en Japonés | MEDLINE | ID: mdl-25918269

RESUMEN

Abscess of corpus cavernosum penis is a rare infection condition. A 69-year-old-man was referred toour hospital with gradual development of penis swelling. T2-weighted magnetic resonance imaging of the pelvis showed abscess formation in the corpus cavernosum. There was no apparent cause of his penile abscess from either history or clinical examination. Open drainage improved his clinical symptoms transiently. However, severe penile pain relapsed, and abscess progressively extended in the corpus cavernosum and spongiosum, necessitating total penectomy. The surgical specimen revealed intensive inflammation and his condition improved immediately after penectomy.


Asunto(s)
Absceso/cirugía , Enfermedades del Pene/cirugía , Procedimientos Quirúrgicos Urológicos Masculinos , Absceso/patología , Anciano , Humanos , Imagen por Resonancia Magnética , Masculino , Enfermedades del Pene/patología , Procedimientos de Cirugía Plástica
17.
Muscle Nerve ; 49(5): 700-8, 2014 May.
Artículo en Inglés | MEDLINE | ID: mdl-23873355

RESUMEN

INTRODUCTION: The active form of vitamin D (1,25-dihydroxy-vitamin D3) is known to increase fast-type myosin heavy chain expression in differentiated myogenic cell lines. The mechanisms for this effect are not fully understood. The aim of this study was to determine the role of signals transmitted through the vitamin D receptor (VDR) during differentiation of myoblasts. METHODS: Electroporation was used to introduce VDR siRNA molecules into C2C12 and G8 murine myoblast cell lines. Gene and protein expression profiles of VDR-gene silenced cells were analyzed in vitro. RESULTS: Suppressing VDR expression by RNA interference resulted in inhibition of myogenic differentiation of C2C12 and G8 cell lines at both mRNA and protein levels. CONCLUSIONS: Our results suggest that myoblasts require signals transmitted through VDR for differentiation into myocytes and emphasize the importance of VDR expression in skeletal muscles for maintaining muscle volume in the elderly.


Asunto(s)
Diferenciación Celular/fisiología , Silenciador del Gen , Desarrollo de Músculos/fisiología , Mioblastos/metabolismo , Receptores de Calcitriol/fisiología , Transducción de Señal/fisiología , Animales , Diferenciación Celular/genética , Línea Celular , Ratones , Células Musculares/metabolismo , Células Musculares/fisiología , Desarrollo de Músculos/genética , Miogenina/genética , Miogenina/metabolismo , Cadenas Pesadas de Miosina/genética , Cadenas Pesadas de Miosina/metabolismo , ARN Interferente Pequeño , Receptores de Calcitriol/genética , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa
18.
Pathol Int ; 64(3): 133-41, 2014 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-24698423

RESUMEN

Renal epithelioid angiomyolipoma (EAML) is a potentially malignant tumor type whose characteristics and biomarkers predictive of malignant behavior have not been elucidated. Here, we report three cases of renal EAML with malignant features but without histories of tuberous sclerosis complex. Case 1 involved a 29-year-old man with a 12-cm solid mass in the right kidney who underwent radical right nephrectomy. Case 2 involved a 22-year-old woman with a retroperitoneal mass who underwent radical right nephrectomy and retroperitoneal tumorectomy. Local recurrence was detected 7 years post-surgery. Case 3 involved a 23-year-old man with a 14-cm solid mass in the left kidney who underwent radical left nephrectomy. Microscopically, the tumors in all cases demonstrated proliferation of epithelioid cells with atypia, mitotic activity, necrosis, hemorrhage, and vascular invasion. Epithelioid cells in all cases were immunohistochemically positive for melanocytic and myoid markers and weakly positive for E-cadherin and ß-catenin. Immunohistochemistry revealed activation of the mammalian target of rapamycin pathway. Here, we report the morphological and immunohistochemical features of clinically or histologically malignant renal EAML.


Asunto(s)
Angiomiolipoma/patología , Células Epitelioides/patología , Neoplasias Renales/patología , Adulto , Angiomiolipoma/metabolismo , Angiomiolipoma/cirugía , Biomarcadores de Tumor/metabolismo , Cadherinas/metabolismo , Células Epitelioides/metabolismo , Femenino , Humanos , Neoplasias Renales/metabolismo , Neoplasias Renales/cirugía , Masculino , Nefrectomía , Resultado del Tratamiento , Adulto Joven , beta Catenina/metabolismo
19.
Urol Int ; 92(1): 122-4, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-24281158

RESUMEN

Renal cell carcinoma (RCC) during pregnancy is rare, and the treatment of this condition requires appropriate steps to treat both the patient and the fetus. To the best of our knowledge, this is the first report to describe a case of RCC with tumor thrombus in the inferior vena cava (IVC) occurring during pregnancy. The affected 46-year-old pregnant woman with placenta previa was clinically diagnosed with cT3bN0M0 RCC at 25 weeks gestation. Therapeutic considerations included risk of sudden pulmonary embolism, risk of thrombosis or intraoperative hemorrhage, and safe delivery of the fetus. After extensive consultation with obstetricians and pediatricians, the surgical management was divided into two steps. First, the patient underwent Caesarean section and simultaneous hysterectomy at 26 weeks gestation. Then, 16 days after delivery, when hemodynamics and hemostasis had improved due to termination of gestation, the patient underwent radical nephrectomy with concomitant IVC thrombectomy.


Asunto(s)
Carcinoma de Células Renales/patología , Neoplasias Renales/patología , Células Neoplásicas Circulantes/patología , Complicaciones Neoplásicas del Embarazo/patología , Vena Cava Inferior/patología , Trombosis de la Vena/patología , Carcinoma de Células Renales/cirugía , Femenino , Edad Gestacional , Humanos , Neoplasias Renales/cirugía , Imagen por Resonancia Magnética , Estadificación de Neoplasias , Nefrectomía , Embarazo , Trombectomía , Factores de Tiempo , Vena Cava Inferior/cirugía , Trombosis de la Vena/cirugía
20.
Int J Urol ; 21(12): 1220-6, 2014 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-25143229

RESUMEN

OBJECTIVES: To assess long-term health-related quality of life in patients undergoing radical prostatectomy. METHODS: A total of 120 patients with at least 5 years of follow up after radical prostatectomy were included in the present study. Health-related quality of life outcomes were assessed using three questionnaires, the Short Form 36-Item Health Survey, the University of California, Los Angeles Prostate Cancer Index and the International Prostate Symptom Score. RESULTS: A total of 91 patients (73%) responded at a median follow-up time of 102 months (range 85-123 months). Among general health-related quality of life domains, mental and role composite summary score remained stable throughout the follow-up period. At the final survey, no significant differences were observed in any of the domains compared with the age-matched average score of the Japanese population. Although the slight decrease in urinary function scores and International Prostate Symptom Score beyond 5 years postoperatively compared with 5 years, the differences were not significant. The sexual function summary score showed a substantially lower score just after radical prostatectomy and remained at a deteriorated level (P < 0.001). Responders at the final survey were more likely to report favorable general, urinary and sexual outcomes at 60 months compared with non-responders. CONCLUSIONS: When taking age-related changes into account, general health-related quality of life seems to remain stable in the long term after radical prostatectomy: patients with favorable health-related quality of life outcomes during the first 5 years after radical prostatectomy maintain favorable outcomes thereafter.


Asunto(s)
Estado de Salud , Prostatectomía , Neoplasias de la Próstata/cirugía , Calidad de Vida , Anciano , Estudios de Seguimiento , Humanos , Japón , Masculino , Persona de Mediana Edad , Periodo Posoperatorio , Neoplasias de la Próstata/psicología , Encuestas y Cuestionarios , Factores de Tiempo , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA